Gollard, R., Flynn, J., Reddy, N., Yusuf, R., Al-Janadi, A. (2025). Zilovertamab vedotin plus R-CHP versus R-CHOP for first-line treatment of diffuse large B-cell lymphoma: The phase 3 waveline-010 study. Blood. https://doi.org/10.1182/blood-2025-5479